-
Today’s Hot List: Newmont Mining Corporation (NYSE:NEM), Affimed N.V. (NASDAQ:AFMD), SunEdison (NYSE:SUNE), GenVec (NASDAQ:GNVC), Jewett-Cameron Trading Company (NASDAQ:JCTCF)
On November 22, Closure of hazardous historic underground mine workings is nearly complete at an abandoned mine complex in Lander County. The work is the result of an 18-month-long collaboration between the Bureau of Land Management and Newmont Mining Corporation (NYSE:NEM). Newmont Mining Corporation (NYSE:NEM) in last trading activity moved down -0.91% to close at…
-
Momentum Stocks: BioDelivery Sciences International (NASDAQ:BDSI), News Corporation (NASDAQ:NWSA), Washington Federal Inc. (NASDAQ:WAFD), Baxter International Inc. (NYSE:BAX), GenVec (NASDAQ:GNVC)
BioDelivery Sciences International Inc. (NASDAQ:BDSI) Director William B. Stone sold 14,000 shares of the stock on the open market in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $16.11, for a total transaction of $225,540.00. BioDelivery Sciences International, Inc. (NASDAQ:BDSI) in last trading activity moved down -3.89% to…
-
Investors Alert: Transocean (NYSE:RIG), RF Micro Devices Inc. (NASDAQ:RFMD), GenVec (NASDAQ:GNVC), AT&T (NYSE:T), Kelly Services (NASDAQ:KELYA)
Transocean Ltd. (NYSE:RIG) will begin trading ex-dividend on November 12, 2014. A cash dividend payment of $0.75 per share is scheduled to be paid on December 17, 2014. Shareholders who purchased RIG stock prior to the ex-dividend date are eligible for the cash dividend payment. Transocean Ltd. (NYSE:RIG) in last trading activity decreased -1.91% to…
-
News Buzz: GenVec (NASDAQ:GNVC), American Airlines Group Inc. (NASDAQ:AAL), Hewlett-Packard Company (NYSE:HPQ), Quicksilver Resources Inc. (NYSE:KWK), Violin Memory (NYSE:VMEM)
GenVec, Inc. (NASDAQ:GNVC) announced that the company has achieved a milestone in its collaboration with Novartis for the development of treatments for hearing and balance disorders. Novartis has dosed the first patient in a clinical study to assess the safety, tolerability, and efficacy of intra-labyrinthine (IL) CGF166 in patients with severe hearing loss. GenVec, Inc.…